Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 15:2020:7436982.
doi: 10.1155/2020/7436982. eCollection 2020.

Investigation of the Role of Oxidative Stress and Factors Associated with Cardiac Allograft Vasculopathy in Patients after Heart Transplantation

Wioletta Szczurek  1 , Mariusz Gąsior  2 , Ewa Romuk  3 , Michał Skrzypek  4 , Michał Zembala  5 , Bożena Szyguła-Jurkiewicz  2
Affiliations

Investigation of the Role of Oxidative Stress and Factors Associated with Cardiac Allograft Vasculopathy in Patients after Heart Transplantation

Wioletta Szczurek et al. Oxid Med Cell Longev. .

Abstract

Oxidative stress is defined as an imbalance between the production of free radicals and their elimination by the antioxidant defense system. However, the role of oxidative stress in cardiac allograft vasculopathy (CAV) has not been fully understood. Therefore, this study is aimed at determining the role of oxidative-antioxidative balance disturbances in patients after HT. Furthermore, we sought to analyze factors associated with the presence of CAV, with particular emphasis placed on oxidative stress markers. The study analyzed data of 194 consecutive patients after HT who underwent routine visits in the Transplantation Clinic between 2015 and 2016. Total oxidant status (TOS) and total antioxidant capacity (TAC) were measured by the method described by Erel. The oxidative stress index (OSI) was defined as the ratio of the TOS to TAC levels. Patients' mean age was 55.4 ± 15.0 years, and 73.4% were men. The frequency of CAV was 50%. The area under the receiver operating characteristic curves indicated a good discriminatory power of TAC and TOS (0.8940 (0.8515-0.9365); 0.8620 (0.8126-0.9114), respectively) as well as excellent discriminatory power of OSI (0.9530 (0.9279-0.9781)) for CAV detection. Multivariate analysis of the Cox proportional hazard model confirmed that OSI (hazard ratio (HR) = 1.294 (1.204-1.391), p < 0.0001), age (HR = 1.023 (1.006-1.041), p = 0.0091), and high-sensitivity C-reactive protein (HR = 1.049 (1.016-1.083), p = 0.0151) were independently associated with CAV presence. In conclusion, TAC and TOS had a good discriminatory power and OSI had excellent strength for detecting CAV. The independent factors of CAV were higher OSI and CRP levels, as well as older recipient age.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
The receiver operating characteristic curves for the TAC (a), TOS (b), and OSI (c).
Figure 2
Figure 2
A division into groups with and without CAV in relation to the cut-off value for OSI.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Lund L. H., Edwards L. B., Kucheryavaya A. Y., et al. The Registry of the International Society for Heart and Lung Transplantation: thirtieth official adult heart transplant report-2013; focus theme: age. The Journal of Heart and Lung Transplantation. 2013;32(10):951–964. doi: 10.1016/j.healun.2013.08.006. - DOI - PubMed
    1. Mehra M. R., Canter C. E., Hannan M. M., et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. The Journal of Heart and Lung Transplantation. 2016;35(1):1–23. doi: 10.1016/j.healun.2015.10.023. - DOI - PubMed
    1. Mehra M. R., Crespo-Leiro M. G., Dipchand A., et al. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy–2010. The Journal of Heart and Lung Transplantation. 2010;29(7):717–727. doi: 10.1016/j.healun.2010.05.017. - DOI - PubMed
    1. Kargin R., Emiroglu M. Y., Evlice M., et al. Role of the oxidative stress index, myeloperoxidase, catalase activity for cardiac allograft vasculopathy in heart transplant recipients. Clinical Transplants. 2018;32(7, article e13273) doi: 10.1111/ctr.13273. - DOI - PubMed
    1. Szyguła-Jurkiewicz B., Szczurek W., Gąsior M., Zembala M. Risk factors of cardiac allograft vasculopathy. Polish Journal of Cardio-Thoracic Surgery. 2015;4(4):328–333. doi: 10.5114/kitp.2015.56783. - DOI - PMC - PubMed